Results 81 to 90 of about 261,124 (307)
Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment
Venous thromboembolism (VTE) is a serious medical condition associated with significant morbidity and mortality, and an incidence that is expected to double in the next forty years.
Allison E. Burnett +5 more
semanticscholar +1 more source
POSS‐PEG‐NHS and GSH cocrosslinked DPAV to prepare a multifunctional anticalcification valve substitute. This modification enhances mechanical properties, hemocompatibility, and re‐endothelialization while promoting anti‐inflammatory M2 macrophage infiltration and reducing calcification.
Yuqing Zhang +10 more
wiley +1 more source
Our SEA strategy provides an efficient and biosafe approach for the on‐demand removal of implanted bioresorbable materials through cascading degradation that couples ultrasound‐triggered rapid mechanical disintegration with subsequent enzymatic degradation.
Jinsong Kim +9 more
wiley +1 more source
Anaesthesia Management for High-risk Patients: A Case Study of Lower Limb Amputation on Anti-thrombolytic Therapy [PDF]
Anaesthesia is associated with certain risks in patients on anticoagulant therapy, which need to be addressed according to clinical requirements. Regional anaesthesia is linked to venous thromboembolism, with increased chances of haematoma and bleeding ...
Prachi Deshmukh, Vivek Chakole
doaj +1 more source
Direct-Acting Oral Anticoagulants and Their Reversal Agents—An Update
Background: Over the last ten years, a new class of drugs, known as the direct-acting oral anticoagulants (DOACs), have emerged at the forefront of anticoagulation therapy.
Stephanie A. Kustos, P. Fasinu
semanticscholar +1 more source
Additively manufactured triply periodic minimal surface (TPMS) membranes offer an architecture‐driven alternative to hollow fiber bundles in artificial lungs. Multiphysics simulations and endothelialized prototypes show that the 3D‐printable membrane architecture improves gas exchange, blood flow distribution, and hemocompatibility, enabling ...
Michael Pflaum +14 more
wiley +1 more source
EXTENDED ANTICOAGULANT THERAPYIN PATIENTS, WHO SURVIVED PULMONARY EMBOLISM
The review article discusses the options to extend anticoagulant therapy after completing the main anticoagulant therapy course in patients, who survived pulmonary embolism.
Natalia M. Vorobieva +1 more
doaj +1 more source
Micro‐ and nanorobots for targeted thrombolysis. This perspective elaborates on the clinical indication of blood clot disorders and current limitations for treatment. As a novel, alternative solution, micro‐ and nanorobots can be used to treat and break down thrombi.
Joshua M. Mesfin +3 more
wiley +1 more source
ABSTRACT Genome‐wide association studies (GWAS) link the Tropomyosin 1 (Tpm1) locus to quantitative blood trait variation, but related mechanisms are unclear. Tpm1 encodes an actin‐binding protein that regulates actin filament diversity, cell adhesion, signaling, and actomyosin contractility.
Po‐Lun Kung +19 more
wiley +1 more source
Prognosis in acute Q-wave myocardial infarction is an actual problem till nowadays. Aim: to determine the different regimens of anticoagulation therapy impact on hospital and one-year mortality, acute postinfarction aneurysm and left ventricle ...
S. M. Kyselov
doaj +1 more source

